ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Thursday Apr 07, 2022
Thursday Apr 07, 2022
In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Apr 06, 2022
Wednesday Apr 06, 2022
Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Apr 05, 2022
Tuesday Apr 05, 2022
This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Apr 04, 2022
Monday Apr 04, 2022
Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Apr 01, 2022
Friday Apr 01, 2022
This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Mar 31, 2022
Thursday Mar 31, 2022
Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Mar 30, 2022
Wednesday Mar 30, 2022
As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Mar 29, 2022
Tuesday Mar 29, 2022
From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Mar 28, 2022
Monday Mar 28, 2022
This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Mar 25, 2022
Friday Mar 25, 2022
Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.